Podoplanin is also expressed in many tumors, including pleural mesotheliomas [45], lymphangioma [46], meningiomas [47], oral [48] and lung squamous cell carcinomas [49], and head and neck cancers [50], making it an exciting target for NIR-PIT. Here, PDPN is linked to pleural mesothelioma.